Deal gives resource-limited countries affordable access to ID testing
By Marley Ghizzone
Hologic, Inc. has partnered with the Clinton Health Access Initiative and MedAccess, which is backed by the United Kingdom government, to increase access to affordable molecular testing for infectious diseases in nearly 50 nations, the partners announced today at the International AIDS Conference in Amsterdam.
“I think this is a great example of a major, global health company taking a look at the developing world and seeing how they can best make a difference,” Alan Staple, vice president of global markets for the Clinton Health Access Initiative, told Infectious Disease News. “The Clinton Health Access Initiative plays a role in creating business solutions that are sustainable for companies, like Hologic, that really meet the needs of populations in low-income countries.”
The Hologic Global Access Initiative will provide countries with affordable molecular diagnostics testing for HIV, hepatitis B virus, hepatitis C virus and HPV, according to a news release. The countries eligible for the program, which are largely in Africa and Southeast Asia, comprise 90% of the global HIV burden.
Photo courtesy of U.S. Army Corps of Engineers Europe District.
- Health Care